PCA-ELISA: A sensitive method to quantify free and masked forms of HMGB1

Cytokine

Volumn 55, Issue 1, 2011, Pages 4-7

  Barnay Verdier, Stéphanie ^a,b   Gaillard, Claire ^a,b   Messmer, Mélanie ^a,b   Borde, Chloé ^a,b   Gibot, Sébastien ^c   Maréchal, Vincent ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

ELISA; EMSA; HMGB1; Interfering factors; Septic shock

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PERCHLORIC ACID; RABBIT ANTISERUM; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPTIC SHOCK; VALIDATION PROCESS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; PERCHLORIC ACID; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

ORYCTOLAGUS CUNICULUS;

EID: 79956373505     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.011     Document Type: Article

References (20)

1. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 2010, 1799:101-113.
2. Bianchi M.E. HMGB1 loves company. J Leuk Biol 2009, 86:573-576.
3. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
4. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004, 170:1310-1316.
5. Sunden-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005, 33:564-573.
6. Gibot S., Massin F., Cravoisy A., Barraud D., Nace L., Levy B., et al. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 2007, 33:1347-1353.
7. Yamada S., Inoue K., Yakabe K., Imaizumi H., Maruyama I. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 2003, 49:1535-1537.
8. Urbonaviciute V., Furnrohr B.G., Weber C., Haslbeck M., Wilhelm S., Herrmann M., et al. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol 2007, 81:67-74.
9. Gaillard C., Borde C., Gozlan J., Marechal V., Strauss F. A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS One 2008, 3:e2855.
10. Gaillard C., Strauss F. High affinity binding of proteins HMGB1 and HMGB2 to semicatenated DNA loops. BMC Mol Biol 2000, 1:1.
11. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008, 180:2531-2537.
12. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 2008, 180:5067-5074.
13. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
14. Barnay-Verdier S, Fattoum L, Borde C, Kaveri S, Gibot S, Maréchal V. Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock. Intensive Care Med 2011 Feb 26 [Epub ahead of print].
15. Thierry S., Gozlan J., Jaulmes A., Boniface R., Nasreddine N., Strauss F., et al. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS 2007, 21:283-292.
16. Angus D.C., Yang L., Kong L., Kellum J.A., Delude R.L., Tracey K.J., et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 2007, 35:1061-1067.
17. Karlsson S., Pettila V., Tenhunen J., Laru-Sompa R., Hynninen M., Ruokonen E. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 2008, 34:1046-1053.
18. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004, 101:296-301.
19. Suda K., Kitagawa Y., Ozawa S., Saikawa Y., Ueda M., Ebina M., et al. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 2006, 30:1755-1762.
20. Stone S.S., Patterson J.M., Phillips M. Isolation and purification of bovine IgM by dissociating immunoglobulin-brucella complexes. J Immunol Methods 1979, 31:379-387.